Literature DB >> 1612442

Pyrolysis mass spectrometry as a method for the classification, identification and selection of actinomycetes.

J J Sanglier1, D Whitehead, G S Saddler, E V Ferguson, M Goodfellow.   

Abstract

Pilot experiments were designed to determine the potential of Curie-point pyrolysis mass spectrometry (PyMS) in the classification, identification and typing of industrially significant actinomycetes, and for the detection of target and novel actinomycetes needed for pharmacological screening programmes. The results indicate that the method is of value for the separation of actinomycetes at and below the species level, in the detection and circumscription of novel actinomycetes, and for the detection of identical and duplicated strains. There is also evidence that the pyrolysis system will permit the identification of target actinomycetes directly from selective isolation plates. PyMS is one of the methods that should be used to generate polyphasic taxonomies of actinomycete genera.

Entities:  

Mesh:

Year:  1992        PMID: 1612442     DOI: 10.1016/0378-1119(92)90564-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

Review 1.  Search and discovery strategies for biotechnology: the paradigm shift.

Authors:  A T Bull; A C Ward; M Goodfellow
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

2.  Differentiation of Micromonospora isolates from a coastal sediment in Wales on the basis of Fourier transform infrared spectroscopy, 16S rRNA sequence analysis, and the amplified fragment length polymorphism technique.

Authors:  Hongjuan Zhao; Yankuba Kassama; Michael Young; Douglas B Kell; Royston Goodacre
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

3.  Rapid detection and high-resolution discrimination of the genus Streptomyces based on 16S-23S rDNA spacer region and denaturing gradient gel electrophoresis.

Authors:  Ho-Shin Park; John J Kilbane
Journal:  J Ind Microbiol Biotechnol       Date:  2005-11-29       Impact factor: 3.346

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.